AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
종목 코드 RCEL
회사 이름AVITA Medical Inc
상장일Mar 18, 2012
CEOMr. James M. (Jim) Corbett
직원 수260
유형Ordinary Share
회계 연도 종료Mar 18
주소28159 Avenue Stanford
도시VALENCIA
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호91355
전화16613679170
웹사이트https://www.avitamedical.com/
종목 코드 RCEL
상장일Mar 18, 2012
CEOMr. James M. (Jim) Corbett
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음